Brief: Fredun Pharma Sees 1.7 Billion Rupees Revenue By 2022
23/02/2021 11:27
Feb 23 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO :
* SEES 1.7 BILLION RUPEES REVENUE BY 2022, MORE THAN 2.1
BILLION
RUPEES BY 2023
Source text for Eikon: ID:nBSEbMdDbN
Further company coverage: FRED.BO
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Fredun Pharmaceuticals
See all newsBrief: Fredun Pharmaceuticals March-Quarter Consol Profit 107.8 Million Rupees
Brief: Fredun Pharmaceuticals Expands Manufacturing Base With Fifth Facility At Palghar
Brief: Fredun Pharmaceuticals Dec-Quarter Consol Profit 104.8 Million Rupees
Brief: Fredun Pharmaceuticals To Issue 652,360 Equity Shares
Brief: Fredun Pharmaceuticals Receives SEBI Adjudication Order